Duration of Symptoms and Plasma Cytokine Levels in Patients with the Common Cold Treated with Zinc Acetate: A Randomized, Double-Blind, Placebo-Controlled Trial
Publication: Annals of Internal Medicine
Volume 133, Number 4
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.
Abstract
Background:
Adults and children in the United States get two to six colds per year. Evidence that zinc is effective therapy for colds is inconsistent.
Objective:
To test the efficacy of zinc acetate lozenges in reducing the duration of symptoms of the common cold.
Design:
Randomized, double-blind, placebo-controlled trial.
Setting:
Detroit Medical Center, Detroit, Michigan.
Patients:
50 ambulatory volunteers recruited within 24 hours of developing symptoms of the common cold.
Intervention:
Participants took one lozenge containing 12.8 mg of zinc acetate or placebo every 2 to 3 hours while awake as long as they had cold symptoms.
Measurements:
Subjective symptom scores for sore throat, nasal discharge, nasal congestion, sneezing, cough, scratchy throat, hoarseness, muscle ache, fever, and headache were recorded daily for 12 days. Plasma zinc and proinflammatory cytokine levels were measured on day 1 and after participants were well.
Results:
Forty-eight participants completed the study (25 in the zinc group and 23 in the placebo group). Compared with the placebo group, the zinc group had shorter mean overall duration of cold symptoms (4.5 vs. 8.1 days), cough (3.1 [95% CI, 2.1 to 4.1] vs. 6.3 [CI, 4.9 to 7.7] days), and nasal discharge (4.1 [CI, 3.3 to 4.9] vs. 5.8 [CI, 4.3 to 7.3] days) and decreased total severity scores for all symptoms (P < 0.002, test for treatment × time interaction). Mean changes in soluble interleukin-1 receptor antagonist level differed nonsignificantly between the zinc group and the placebo group (difference between changes, −89.4 pg/mL [CI, −243.6 to −64.8 pg/mL]).
Conclusion:
Administration of zinc lozenges was associated with reduced duration and severity of cold symptoms, especially cough. Improvement in clinical symptoms with zinc treatment may be related to a decrease in proinflammatory cytokine levels; however, in this study, the observed differences between changes in cytokine levels in zinc and placebo recipients were not significant.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Dingle JH, Badger GF, Jordan WS Jr. Illness in the Home: Study of 25,000 illnesses in a Group of Cleveland Families. Cleveland: Pr of Case Western Reserve Univ; 1964.
2.
Gwaltney JM Jr, Hendley JO, Simon G, Jordan WS Jr. Rhinovirus infections in an industrial population. I. The occurrence of illness. N Engl J Med. 1966;275:1261-8.
3.
Couch RB. The common cold: control? J Infect Dis. 1984;150:167-73.
4.
Eby GA, Davis DR, Halcomb WW. Reduction in duration of common cold by zinc gluconate lozenges in a double-blind study. Antimicrob Agents Chemother. 1984;25:20-4.
5.
Al-Nakib W, Higgins PG, Barrow I, Batstone G, Tyrrell DA. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother. 1987;20:893-901.
6.
Godfrey JC, Conant Sloane B, Smith DS, Turco JH, Mercer N, Godfrey NH. Zinc gluconate and the common cold: a controlled clinical study. J Int Med Res. 1992;20:234-46.
7.
Mossad SB, Macknin ML, Medendorp SV, Mason P. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study. Ann Intern Med. 1996;125:81-8.
8.
Petrus EJ, Lawson KA, Bucci LR, Blum K. Randomized, double-masked, placebo-controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects. Current Therapeutic Research. 1998;59:595-606.
9.
Farr BM, Conner EM, Betts RF, Oleske J, Minnefor A, Gwaltney JM Jr. Two randomized, controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus cold. Antimicrob Agents Chemother. 1987;31:1183-7.
10.
Douglas RM, Miles HB, Moore BW, Ryan P, Pinnock CB. Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infection of Australian adults. Antimicrob Agents Chemother. 1987;31:1263-5.
11.
Smith DS, Helzner EC, Nuttall CE Jr, Collins M, Rofman BA, Ginsberg D, et al . Failure of zinc gluconate in treatment of acute upper respiratory tract infections. Antimicrob Agents Chemother. 1989;33:646-8.
12.
Weismann E, Jakobsen JP, Weismann JE, Hammer UM, Nyholm SM, Hansen B, et al . Zinc gluconate lozenges for common cold. A double-blind clinical trial. Dan Med Bull. 1990;37:279-81.
13.
Macknin ML, Piedmonte M, Calendine C, Janosky J, Wald E. Zinc gluconate lozenges for treating common cold in children. JAMA. 1998;279:1962-7.
14.
Eby GA. Linearity in dose-response from zinc lozenges in treatment of common colds. The Journal of Pharmacy Technology. 1995;11:110-22.
15.
Korant BD, Butterworth BE. Inhibition by zinc of rhinovirus protein cleavage: interaction of zinc with capsid polypeptides. J Virol. 1976;18:298-306.
16.
Moffat AS. Going back to the future with small synthetic compounds. Science. 1993;260:910-2.
17.
Novick SG, Godfrey JC, Godfrey NJ, Wilder HR. How does zinc modify the common cold? Clinical observations and implications regarding mechanism of action. Med Hypotheses. 1996;46:295-302.
18.
Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al . Improving the quality of reporting of randomized, controlled trials. The CONSORT statement. JAMA. 1996;276:637-9.
19.
Prasad AS. Biochemistry of Zinc. New York: Plenum; 1993:279-9.
20.
Hatch B, Berthon G. Metal ion-FTS nonapeptide interactions. A quantitative study of zinc(II)-nonapeptide complexes (thymulin) under physiological conditions and assessment of their biological significance. Inorganica Chimica Acta. 1987;136:165-71.
21.
Farr BM, Hyden FG, Gwaltney J Jr. Zinc gluconate lozenges for treating the common cold [Letter]. Ann Intern Med. 1997;126:738.
22.
Davidoff F. Where's the bias? [Letter]. Ann Intern Med. 1998;128:75.
23.
Jackson JL, Peterson C, Lesho E. A meta-analysis of zinc salts lozenges and the common cold. Arch Intern Med. 1997;157:2373-6.
24.
Geist FC, Bateman JA, Hayden FG. In vitro activity of zinc salts against human rhinoviruses. Antimicrob Agents Chemother. 1987;31:622-4.
25.
Catania A, Airaghi L, Motta P, Manfredi MG, Annoni G, Pettenati C, et al . Cytokine antagonists in aged subjects and their relation withcellular immunity. J Gerontol A Biol Sci Med Sci. 1997;52:B93-7.
26.
Fuchs D, Hansen A, Reibnegger D, Werner ER, Dierich MP, Wachter H, et al . Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol Today. 1988;9:150-5.
27.
Catania A, Manfredi MG, Airaghi L, Ceriani G, Gandino A, Lipton JM, et al . Cytokine antagonists in infections and inflammatory disorders. Ann N Y Acad Sci. 1994;741:149-61.
28.
Arend WP. Interleukin 1 receptor antagonist. A new member of interleukin 1 family. J Clin Invest. 1991;88:1445-51.
29.
Koch AE, Kunkel SL, Strieter RM. Cytokines in rheumatoid arthritis. J Invest Med. 1995;43:28-38.
30.
Bui LM, Dressendorfer RH, Keen CL, Summary JJ, Dubick MA. Zinc status and interleukin-1 β-induced alterations in mineral metabolism in rats. Proc Soc Exp Biol Med. 1994;206:438-44.
31.
Wahl SM, Wong H, McCartney-Francis N. Role of growth factors in inflammation and repair. J Cell Biochem. 1989;40:193-9.
32.
Pitkaranta A, Hayden FG. What's new with common colds? Pathogenesis and diagnosis. Infections in Medicine. 1998;15:50-9.
33.
Noah TL, Henderson FW, Wortman IA, Devlin RB, Handy J, Koren HS, et al . Nasal cytokine production in viral acute upper respiratory infections of childhood. J Infect Dis. 1995;171:584-92.
34.
Stockl J, Vetr H, Majic O, Zlabinger G, Kuechler E, Knapp W. Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10. J Clin Invest. 1999;104:957-65.
35.
Beck FW, Prasad AS, Kaplan J, Fitzgerald JT, Brewer GJ. Changes in cytokines production and T cell subpopulations in experimentally induced zinc-deficient humans. Am J Physiol. 1997;272:E1002-7.
36.
Turner RB, Wecker MT, Pohl G, Witek TJ, McNally E, St George R, et al . Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. JAMA. 1999;281:1797-804.
37.
Prasad AS. Biochemistry of Zinc. New York: Plenum; 1993:259-78.
Information & Authors
Information
Published In
Annals of Internal Medicine
Volume 133 • Number 4 • 15 August 2000
Pages: 245 - 252
History
Published online: 15 August 2000
Published in issue: 15 August 2000
Keywords
Copyright
© 2000 American College of Physicians.
Authors
Metrics & Citations
Metrics
Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
Download article citation data for:
Duration of Symptoms and Plasma Cytokine Levels in Patients with the Common Cold Treated with Zinc Acetate: A Randomized, Double-Blind, Placebo-Controlled Trial. Ann Intern Med.2000;133:245-252. [Epub 15 August 2000]. doi:10.7326/0003-4819-133-4-200008150-00006
Duration of Symptoms and Plasma Cytokine Levels in Patients with the Common Cold Treated with Zinc Acetate: A Randomized, Double-Blind, Placebo-Controlled Trial. Ann Intern Med.2000;133:245-252. [Epub 15 August 2000]. doi:10.7326/0003-4819-133-4-200008150-00006
View More
Login Options:
Purchase
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
Access to EPUBs and PDFs for FREE Annals content requires users to be registered and logged in. A subscription is not required. You can create a free account below or from the following link. You will be redirected to acponline.org to create an account that will provide access to Annals. If you are accessing the Free Annals content via your institution's access, registration is not required.
Create your Free Account
You will be redirected to acponline.org to create an account that will provide access to Annals.
Comments
0 Comments